SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-21-000259
Filing Date
2021-07-08
Accepted
2021-07-08 15:02:28
Documents
13
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. avricore6kapril2021.htm 6-K 11823
2 EXHIBIT 99.1 ab13501f1_ex99z1.htm EX-99.1 1529
3 EXHIBIT 99.2 avcfinancials_ex99z2.htm EX-99.2 314769
4 EXHIBIT 99.3 mda_ex99z3.htm EX-99.3 118060
5 EXHIBIT 99.4 ceocert_ex99z4.htm EX-99.4 6024
6 EXHIBIT 99.5 cfocert_ex99z5.htm EX-99.5 6012
7 IMAGE ab13501f1ex99z1_1.jpg GRAPHIC 144448
8 IMAGE ab13501f1ex99z1_2.jpg GRAPHIC 137892
9 IMAGE ab13501f1ex99z1_3.jpg GRAPHIC 161135
10 IMAGE ab13501f1ex99z1_4.jpg GRAPHIC 43122
11 IMAGE avcfinancialsex99z2_1.jpg GRAPHIC 6914
12 IMAGE avcfinancialsex99z2_2.jpg GRAPHIC 716176
13 IMAGE mdaex99z3_1.jpg GRAPHIC 6914
  Complete submission text file 0001052918-21-000259.txt   2124081
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 211080035
SIC: 2834 Pharmaceutical Preparations